Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
KP Tissue (TSE:KPT)
:KPT
Holding TSE:KPT?
Track your performance easily
Earnings Data
Report Date
Mar 06, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.15Last Year’s EPS
-0.82Same Quarter Last Year
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 08, 2018
|% Change Since: 1.13%
|Next Earnings Date:Aug 09, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mixed view. While there was strong revenue growth and significant achievements like the Sherbrooke expansion, the company faced challenges with declining EBITDA and increased costs impacting margins. The sentiment is balanced with positive growth offset by operational challenges.Company Guidance
During the third quarter of 2024 earnings call for KP Tissue, the company provided guidance indicating a strong performance with a revenue growth of 10.1%, driven by higher sales volume and favorable selling prices, particularly in the U.S. market where sales improved by 16.1%. The company reported an adjusted EBITDA of $65.7 million, although this represented a year-over-year decline of 9.3% due to higher pulp prices, increased freight rates, and SG&A expenses. The net income for the quarter increased to $18 million, up from $12.9 million in Q3 2023, benefitting from a $13.7 million FX gain and lower income tax expenses. The completion of the Sherbrooke manufacturing plant, including the start-up of a new LDC paper machine with a 60,000 metric ton capacity, was highlighted as a significant operational milestone. Looking forward, the company expects Q4 2024 adjusted EBITDA to remain in the range of Q3, supported by higher selling prices and slightly lower input costs. The company's financial outlook anticipates a decrease in leverage ratio and a reduction in capital expenditure for 2025, signaling a focus on cost management and operational efficiency.Double-Digit Revenue Growth
Revenue growth of 10.1% in Q3 2024 was driven by higher sales volume and favorable pricing. U.S. sales improved by 16.1% and Canadian revenues increased by 5.5%.
Sherbrooke Expansion Success
The complete construction and successful start-up of the Sherbrooke manufacturing plant, enhancing production capacity by 60,000 metric tons, was a major operational highlight.
Net Income Increase
Net income increased by $5.1 million from Q3 2023, totaling $18 million in Q3 2024, attributed to higher FX gain and lower income tax expense.
Leadership in Canadian Tissue Market
The company maintained a leadership position with a 44% share in the Canadian facial tissue market and gained shares in bathroom tissue and paper towels.
---
TSE:KPT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:KPT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 13, 2024 | C$7.99 | C$8.20 | +2.63% |
| Aug 13, 2024 | C$8.14 | C$8.11 | -0.37% |
| May 14, 2024 | C$7.71 | C$7.68 | -0.39% |
| Mar 07, 2024 | C$7.89 | C$7.78 | -1.39% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does KP Tissue (TSE:KPT) report earnings?
KP Tissue (TSE:KPT) is schdueled to report earning on Mar 06, 2025, TBA Not Confirmed.
What is KP Tissue (TSE:KPT) earnings time?
KP Tissue (TSE:KPT) earnings time is at Mar 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:KPT EPS forecast?
TSE:KPT EPS forecast for the fiscal quarter 2024 (Q4) is 0.15.
---